Elizabeth H.Z. Thompson

Insider Reports History

Entity
Individual
Location
C/O Horizon Therapeutics, Inc., 2 Tower Place, 12 Th Floor, South San Francisco, California
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elizabeth H.Z. Thompson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ACADIA PHARMACEUTICALS INC EVP, Head of Research & Dev Restricted Stock Units 64.5K $955K $14.79 Aug 12, 2024 Direct
IGM Biosciences, Inc. Director Common Stock 2.9K $22K $7.58 Jun 28, 2024 Direct
ACADIA PHARMACEUTICALS INC EVP, Head of Research & Dev Stock Option (Right to Buy) 325K Aug 12, 2024 Direct
IGM Biosciences, Inc. Director Stock Option (right to buy) 29.4K Mar 12, 2024 Direct
Horizon Therapeutics Public Ltd Co EVP, Research & Development Ordinary Shares 0 $116.50 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Research & Development Performance Restricted Stock Units 0 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Research & Development Restricted Stock Units 0 Oct 6, 2023 Direct

Insider Reports Filed by Elizabeth H.Z. Thompson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACAD ACADIA PHARMACEUTICALS INC Aug 12, 2024 2 $0 4 Aug 13, 2024 EVP, Head of Research & Dev
IGMS IGM Biosciences, Inc. Jun 28, 2024 1 $0 4 Jul 2, 2024 Director
ACAD ACADIA PHARMACEUTICALS INC Apr 4, 2024 0 $0 3 Apr 15, 2024 EVP, Head of Research & Dev
IGMS IGM Biosciences, Inc. Mar 29, 2024 1 $0 4 Apr 2, 2024 Director
IGMS IGM Biosciences, Inc. Mar 12, 2024 1 $0 4 Mar 14, 2024 Director
HZNP Horizon Therapeutics Public Ltd Co Oct 6, 2023 10 -$1.7M 4 Oct 6, 2023 EVP, Research & Development
IGMS IGM Biosciences, Inc. Oct 3, 2023 1 $0 4 Oct 5, 2023 Director
IGMS IGM Biosciences, Inc. Oct 3, 2023 0 $0 3 Oct 5, 2023 Director
HZNP Horizon Therapeutics Public Ltd Co Mar 13, 2023 1 $0 4 Mar 14, 2023 EVP, Research & Development
HZNP Horizon Therapeutics Public Ltd Co Jan 4, 2023 1 $0 4 Jan 6, 2023 EVP, Research & Development
HZNP Horizon Therapeutics Public Ltd Co Dec 30, 2022 5 -$1.08M 4 Jan 4, 2023 EVP, Research & Development
HZNP Horizon Therapeutics Public Ltd Co Jul 19, 2022 3 -$511K 4 Jul 20, 2022 EVP, Research & Development
HZNP Horizon Therapeutics Public Ltd Co Jul 7, 2022 1 -$6.97K 4 Jul 11, 2022 EVP, Research & Development
HZNP Horizon Therapeutics Public Ltd Co Apr 18, 2022 1 -$936K 4 Apr 20, 2022 EVP, Research & Development
HZNP Horizon Therapeutics Public Ltd Co Jan 4, 2022 6 -$716K 4 Jan 6, 2022 EVP, Research & Development
HZNP Horizon Therapeutics Public Ltd Co Aug 5, 2021 1 -$802K 4 Aug 6, 2021 EVP, Research & Development
HZNP Horizon Therapeutics Public Ltd Co Jul 1, 2021 3 -$578K 4 Jul 2, 2021 EVP, Research & Development
HZNP Horizon Therapeutics Public Ltd Co Apr 29, 2021 0 $0 3 May 10, 2021 EVP, Research & Development